In particular, because the intact portions of the ATPase domain and binding regions are required for ATAD3A function in cancer cells, several approaches have been developed around the inhibition of these portion’s transcription and translation to block ATAD3A’s ATPase activity. This evidence concerns the gene ATAD3A and cancer.